MedTrace Logo

Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer

NCT01692951 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2017-06-20

Study results available
· View outcomes & findings →

Summary

This study aims to evaluate the performance of serum free fatty acids as biomarkers for the identification of lung cancer.

Conditions

Interventions

OTHER

serum sample

Serum samples from lung cancer patients were collected at the time of their diagnosis, prior to the initiation of treatment. Serum samples of control subjects were collected from a biobank

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Daniel Sessler, M.D. · The Cleveland Clinic

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01692951 on ClinicalTrials.gov